Study of aletekitug for moderate to severe ulcerative colitis
Part of Digestive system clinical trials.
This study tests a new medicine called aletekitug for people with moderate to severe ulcerative colitis (UC). It aims to see if it's safe and if it can help control symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had ulcerative colitis for at least 3 months, with active disease.
- Your disease is moderate to severe, as measured by a standard score.
- Your disease extends beyond the rectum (more than 15 cm from the anus).
- You had a colonoscopy within the past year if you have had extensive colitis for over 8 years or left-sided colitis for over 12 years.
- You have not responded well to or could not tolerate standard treatments like 5-ASA drugs, steroids, or thiopurines.
- You have not had certain treatments like biologics or small molecules for UC, or you have been off them for a required period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests several new treatments to see if they are safe and helpful for people with moderate to severe ulcerative colitis. If you have not responded well to standard treatments, this might be an option.
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
This trial tests a new medicine called SAR441566 for people with moderate-to-severe ulcerative colitis (UC). It may help reduce symptoms like bleeding and diarrhea if other treatments haven't worked well enough.
This study tests a new drug called JNJ-78934804 to treat ulcerative colitis (inflammation of the colon and rectum) that is moderate to severe and hasn't responded well to standard treatments. The goal is to see if this drug can reduce inflammation and improve symptoms.
This trial tests an investigational drug called MK-8690 for people with moderate to severe ulcerative colitis (UC) who haven't responded well to other treatments or can't tolerate them. The study aims to see if the drug can help control UC symptoms safely.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
Hear when a new Colitis, Ulcerative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.